Orchestra BioMed Holdings, Inc. (OBIO) stock
OBIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$6.97−0.15 (-2.11%)
Close on Nov 17, 2026Market cap $418.93MP/E –Yield –
Orchestra BioMed gross margin
Gross margin is gross profit as a percentage of revenue.
Orchestra BioMed's gross margin for the twelve months ending Jun 30, 2026 was 99.5%. For fiscal 2025 it was 99.4%, against 92.3% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 99.4% | +7.2 |
| FY2024 | Dec 31, 2024 | 92.3% | −1.0 |
| FY2023 | Dec 31, 2023 | 93.3% | −0.8 |
| FY2022 | Dec 31, 2022 | 94.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 71.6% | −22.9 |
| Q1 FY2026 | Mar 31, 2026 | 70.9% | −24.0 |
| Q4 FY2025 | Dec 31, 2025 | 99.8% | +22.8 |
| Q3 FY2025 | Sep 30, 2025 | 94.3% | +1.2 |
| Q2 FY2025 | Jun 30, 2025 | 94.5% | +0.2 |
| Q1 FY2025 | Mar 31, 2025 | 94.9% | +0.4 |
| Q4 FY2024 | Dec 31, 2024 | 77.1% | −5.0 |
| Q3 FY2024 | Sep 30, 2024 | 93.1% | +2.9 |
| Q2 FY2024 | Jun 30, 2024 | 94.3% | +0.2 |
| Q1 FY2024 | Mar 31, 2024 | 94.5% | −1.7 |
| Q4 FY2023 | Dec 31, 2023 | 82.1% | −13.1 |
| Q3 FY2023 | Sep 30, 2023 | 90.2% | −5.0 |
| Q2 FY2023 | Jun 30, 2023 | 94.1% | +9.1 |
| Q1 FY2023 | Mar 31, 2023 | 96.2% | +1.1 |
| Q4 FY2022 | Dec 31, 2022 | 95.2% | – |
| Q3 FY2022 | Sep 30, 2022 | 95.2% | – |
| Q2 FY2022 | Jun 30, 2022 | 85.0% | – |
| Q1 FY2022 | Mar 31, 2022 | 95.2% | – |
See a number that looks wrong?